SCHEMBL10241220

SCHEMBL10241220

CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3ccc(OC(C)C)c(C(=O)NC4(c5ccccn5)CC4)c3)cc12

nearest known ligand 0.67

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYP2C8 P10632 6/20 0.67
CYP3A4 P08684 5/20 0.67
KCNH2 Q12809 3/20 0.67
NR1I2 O75469 1/20 0.67
ADORA2A P29274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12390463 0.92 CYP2C8 (0.68) CYP2C8CYP3A4KCNH2NR1I2
SCHEMBL2138413 0.91 CYP2C8 (0.73) CYP2C8CYP3A4KCNH2NR1I2
SCHEMBL1918440 0.87 CYP2C8 (0.71) CYP2C8CYP3A4KCNH2NR1I2
SCHEMBL2142742 0.85 CYP2C8 (0.71) CYP2C8CYP3A4KCNH2NR1I2ADORA2A
SCHEMBL2140231 0.85 CYP2C8 (0.77) CYP2C8CYP3A4KCNH2NR1I2
SCHEMBL2138597 0.84 CYP2C8 (0.76) CYP2C8CYP3A4KCNH2NR1I2ADORA2A
SCHEMBL2141956 0.84 CYP2C8 (0.71) CYP2C8CYP3A4KCNH2NR1I2
SCHEMBL10242001 0.84 CYP2C8 (0.80) CYP2C8CYP3A4KCNH2NR1I2
SCHEMBL2140436 0.84 CYP2C8 (0.69) CYP2C8CYP3A4KCNH2NR1I2
SCHEMBL1920115 0.84 CYP2C8 (0.69) CYP2C8CYP3A4KCNH2NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148382-B2 Compounds for the treatment of hepatitis C BRISTOL-MYERS SQUIBB COMPANY (US) 2012-04-03 US disclosed
US-8148382-B2 Compounds for the treatment of hepatitis C BRISTOL-MYERS SQUIBB COMPANY (US) 2012-04-03 US disclosed